This is a routine proxy supplement confirming a previously announced CEO transition. Monitor the annual meeting outcome on May 7 for any dissident activity or shareholder dissent, but no immediate trading action is warranted based on this filing alone.
Price Chart
Executive Summary
Integra LifeSciences filed a DEFA14A proxy supplement confirming that former CEO Mojdeh Poul will not stand for election at the May 7, 2026 annual meeting following her departure on April 30, 2026. Chairman Stuart Essig has been appointed President and CEO, and the board has been reduced from eight to seven directors. This is a procedural update to the proxy statement — no financial impact or material change to the company's operations.
Key Financial Metrics
Key Facts
- Mojdeh Poul ceased as President/CEO and director effective April 30, 2026
- Stuart Essig appointed President and CEO effective May 1, 2026, continuing as Chairman
- Board reduced from eight to seven directors
- Annual meeting remains scheduled for May 7, 2026 at 9:00 a.m. local time
- No new proxy card will be issued; previously submitted proxies for Poul will not be voted for her election
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- Potential shareholder dissatisfaction with the CEO transition process
- Uncertainty around strategic direction under returning former CEO Stuart Essig
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0000917520-26-000038 |
| Document: 0000917520-26-000038-index-headers.html | 0000917520-26-000038 |
| Document: 0000917520-26-000038-index.html | 0000917520-26-000038 |
| Document: 0000917520-26-000038.txt | 0000917520-26-000038 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 8-K | $11.84 | awaiting T+5 | — | $12.12 (−2.36%) |
Oct 19, 2026 6d ago | 8-K | $13.33 | awaiting T+5 | — | $12.12 (−9.08%) |
Oct 14, 2026 12d ago | Court Ruling | $13.53 $12.33 | ▼ −8.91% | ▼ −7.89% | $12.12 (−10.42%) |
Oct 13, 2026 12d ago | 3 | $13.18 $11.84 | ▼ −10.13% | ▼ −10.59% | $12.12 (−8.01%) |
Oct 9, 2026 16d ago | 8-K | $13.98 $13.45 | ▲ +3.79% | ▲ +2.30% | $12.12 (+13.30%) |
Oct 6, 2026 20d ago | Press Release | $13.32 | awaiting T+5 | — | $12.12 (−9.01%) |
Oct 2, 2026 24d ago | 8-K | $12.68 $13.44 | ▼ −5.99% | ▼ −4.83% | $12.12 (+4.42%) |
Oct 2, 2026 24d ago | Press Release | $12.68 $13.44 | ▼ −5.99% | ▼ −4.83% | $12.12 (+4.42%) |
Sep 8, 2026 6w ago | 8-K | $16.26 $15.71 | ▼ −3.38% | ▼ −2.72% | $12.12 (−25.46%) |
May 8, 2026 24w ago | 8-K | $13.97 $14.11 | ▲ +1.00% | ▲ +1.09% | $12.12 (−13.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers